Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
Liguo Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Changjun Bao(Jiangsu Provincial Center for Disease Control and Prevention), Naiying Mao(Centers for Disease Control and Prevention), Lü Zhou(Hebei Medical University), Changhua Yi(Nanjing University of Chinese Medicine), Aidibai Simayi(Southeast University), Shihan Zhang(Peking University), Jun Zhao(Northern Jiangsu People's Hospital), Jialu Feng(Nanjing Medical University), Ci Song(Nanjing Medical University), Songning Ding(Jiangsu Provincial Center for Disease Control and Prevention), Mingwei Wei(Jiangsu Provincial Center for Disease Control and Prevention), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Yan Wang(University of California, Los Angeles), Yin Wang(North China Electric Power University), Jie Hong(Changchun University of Science and Technology), Chuchu Li(Hebei University of Science and Technology), Yi Feng(Chinese Center For Disease Control and Prevention), Wenbo Xu(National Institute for Viral Disease Control and Prevention), Min He(Army Medical University), Jiefu Peng(Jiangsu Provincial Center for Disease Control and Prevention), Hui Jin(University of Electronic Science and Technology of China)
Cited by 7
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice
|Molecular Psychiatry|2004|275
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204